Target intelligence / Profile preview

CD2 antigen (T-cell surface antigen CD2) (CD2)

Target
CD2
Molecular classification
Receptor, Cell adhesion molecule, Immunoglobulin superfamily (IgSF) member
01

Overview

CD2 antigen (CD2) is a transmembrane glycoprotein found predominantly on the surface of almost all peripheral T lymphocytes and thymocytes[1][2][5]. It belongs to the immunoglobulin superfamily and acts primarily as a cell adhesion molecule and signal transducer, facilitating adhesion between T cells and antigen-presenting cells (APCs) via interaction with its primary ligand CD58 (LFA-3 in humans)[1][3][6][7]. CD2 plays a significant role in the formation and organization of the immunological synapse, enhancing T cell receptor (TCR) signaling and T cell activation[2][3][6]. It is also involved in rearrangement of the actin cytoskeleton and participates in costimulatory signaling crucial for effective immune responses[2][5]. CD2-targeting therapies (such as alefacept, siplizumab) aim to modulate T cell responses for conditions like autoimmune disease and transplantation, but are associated with safety concerns including immunosuppression and increased infection risk[2].

Other names
T-cell surface antigen CD2E-rosette receptorLFA-2leukocyte function-associated antigen 2sheep erythrocyte receptorT11 antigen
02

Mechanism of action

Blocking CD2-LFA-3 (CD58) interaction, Modulating T-cell activation, Immunosuppression via T-cell depletion or inhibition

03

Biological functions

Immune responseSignal transductionCell adhesionT cell activationFormation of immunological synapseActin cytoskeleton rearrangementCostimulation in T-cell signaling
04

Disease associations

CancerInflammationInfectionAutoimmune diseaseTransplant rejection
05

Safety considerations

Increased risk of infections due to immunosuppressionPossible effects on normal T cell functionOff-target immunosuppression in therapeutic applications
06

Interacting drugs

Alefacept

1 more in the full profile.

07

Biomarkers

CD2 surface expression (for T-cell identification, patient selection in T-cell lymphomas or immunotherapy monitoring)

Beyond the preview

Go deeper on CD2 antigen (T-cell surface antigen CD2) (CD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD2 antigen (T-cell surface antigen CD2) (CD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call